Funding Bolsters Effort to Bring Newborn Screening to Eastern Canada

Funding Bolsters Effort to Bring Newborn Screening to Eastern Canada

313320

Funding Bolsters Effort to Bring Newborn Screening to Eastern Canada

A CA$414,000 grant was awarded to the Maritimes by Muscular Dystrophy Canada (MDC) and Novartis Pharmaceuticals Canada to further support the implementation of newborn screening for spinal muscular atrophy (SMA). The funding (about $322,600), received by the Maritime Newborn Screening Program (MNSP), will go toward work to overcome challenges that may arise while trying to add SMA to the newborn screening panel. MNSP, located in the IWK Health Centre, serves the provinces of this eastern…

You must be logged in to read/download the full post.